# Engineered Energy-Harvesting Hybrid Nanoscintillators for Enhanced Cancer Radiotherapy

**Authors:** Valeria Secchi, Irene Villa, Samuela Sala, Alessandro Colombo, Stefania Garbujo, Miriam Colombo, Angelo Monguzzi

PMC · DOI: 10.1021/acsami.6c02336 · ACS Applied Materials & Interfaces · 2026-03-06

## TL;DR

This paper introduces a new nanomaterial that boosts cancer cell-killing during radiotherapy by enhancing energy harvesting and ROS production.

## Contribution

A novel hybrid nanoscintillator design that significantly improves singlet oxygen generation during radiotherapy.

## Key findings

- The nanomaterial increased singlet oxygen generation by nearly two orders of magnitude compared to previous systems.
- It demonstrated excellent glioblastoma cell-killing efficiency at low concentrations.
- The architecture optimizes energy harvesting from ionizing radiation for localized ROS production.

## Abstract

During treatment, ionizing radiation interacts with biological
tissues, generating high-energy charges that diffuse through the medium,
damaging cellular DNA, or inducing the formation of cytotoxic reactive
oxygen species (ROS) via water radiolysis. To enhance and localize
ROS production by improving the interaction with ionizing radiation
and optimizing the harvesting and utilization of deposited energy,
we designed and developed a multicomponent nanomaterial as a prototype
for the creation of coadjutant agents aimed at improving the efficacy
and safety of radiotherapy. The system consists of a dense biocompatible
magnesium silicate nanotube core, which enhances interaction with
ionizing radiation, decorated with a dual layer of conjugated photosensitizers
for singlet oxygen and ROS generation. Thanks to this optimized architecture
that boosts the harvesting of the energy deposited by the ionizing
radiation, exposure to X-rays resulted in a dramatic increase of almost
2 orders of magnitude in singlet oxygen generation yield compared
to previously studied systems. This was accompanied by an excellent
glioblastoma cell-killing efficiency at low concentrations, thus,
strongly supporting the proposed nanomaterial architecture as a model
for the development of next-generation radiotherapy coadjutants.

## Linked entities

- **Chemicals:** singlet oxygen (PubChem CID 159832)
- **Diseases:** glioblastoma (MONDO:0018177)

## Full-text entities

- **Diseases:** Cancer (MESH:D009369), glioblastoma (MESH:D005909)
- **Chemicals:** singlet oxygen (MESH:D026082), water (MESH:D014867), ROS (MESH:D017382), magnesium silicate (MESH:C005013)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006953/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13006953/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006953/full.md

---
Source: https://tomesphere.com/paper/PMC13006953